cas 1396631-17-6|| where to buy 1-(2-methoxyphenyl)-2-[4-(1,2,3,4-tetrahydroisoquinoline-2-carbonyl)-1H-1,2,3-triazol-1-yl]ethan-1-ol

Nombre del producto:1-(2-methoxyphenyl)-2-[4-(1,2,3,4-tetrahydroisoquinoline-2-carbonyl)-1H-1,2,3-triazol-1-yl]ethan-1-ol

IUPAC Name:1-(2-methoxyphenyl)-2-[4-(1,2,3,4-tetrahydroisoquinoline-2-carbonyl)-1H-1,2,3-triazol-1-yl]ethan-1-ol

Unidad de embalaje	Stock disponible	Precio($)	Cantidad

Sólo para uso en I+D..

Formulario de consulta

Nombre químico

Número CAS

Cantidad*

Especificaciones requeridas*
(% de ensayo, grado de material, etc.)

Nombre de contacto*

Correo electrónico de contacto*

Meanwhile I'd like to create a registered account on CHEMENU.COM with the above email.

I'd like to receive emails related to products with similar structures to 1396631-17-6 regularly via the above email.

Notas adicionales

Verification code*

refresh

: Núm. De CAS :1396631-17-6; Fórmula molecular:C21H22N4O3; Punto de fusión:-; Código de sonrisas:COC1=C(C=CC=C1)C(O)CN1C=C(N=N1)C(=O)N1CCC2=C(C1)C=CC=C2; Densidad:

: Número de catálogo:CM792494; Peso molecular:378.43; Punto de ebullición:; Nº Mdl:; Almacenamiento:

: Triazoles; Triazole refers to a heterocyclic compound with the molecular formula C2H3N3, which has a five-membered ring consisting of two carbon atoms and three nitrogen atoms. Neurodegenerative diseases such as Alzheimer's disease and Parkinson's disease already affect many people around the world, and these numbers are increasing rapidly. Treatment for these disorders is often aimed at relieving symptoms and has no cure. Research on new molecules is underway, and heterocyclic compounds have important pharmacological implications. Triazoles and tetrazoles are emerging as new molecules in this field.

: Tetrahydroisoquinolines; Tetrahydroisoquinoline is an organic compound with the chemical formula C9H11N. It is classified as a secondary amine, obtained from isoquinoline by hydrogenation. The tetrahydroisoquinoline moiety forms the backbone of several natural, synthetic and semi-synthetic drugs approved for the treatment of cancer, pain, gout and various neurodegenerative diseases.